FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Ultima Genomics, Inc., a developer of an ultra-high-throughput sequencing architecture, today announced the commercial launch of UG 100 Solaris at the ...
“UG 100 Solaris, providing even higher throughput, lower cost, and broader support for key applications technologies…” “Only one year after commercially launching our UG 100 sequencing platform, we ...
By reducing sequencing run times, UG 100 Solaris Boost can further increase the output of the UG 100 sequencing platform to up to 100 billion reads per day for short-read applications. We have begun ...